Screener
Merit Medical Systems MMSI Single Reportable — Income Tax Expense Benefit
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Merit Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Merit Medical Systems’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:23 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000856982-26-000025
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Cost of sales other(2) | 50,063 | 40,528 |
| Selling and marketing expenses | 73,957 | 64,929 |
| General and administrative expenses | 44,253 | 42,557 |
| Research and development expenses | 22,609 | 22,478 |
| Other operating expenses(3) | (179) | 1,023 |
| Other (income) expense — net | (9,389) | 3,075 |
| Income tax expense | 12,551 | 7,811 |
| Net income | $40,995 | $30,147 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Merit Medical Systems's single reportable — income tax expense benefit?
- Merit Medical Systems (MMSI) reported single reportable — income tax expense benefit of $12.55M in Q1 2026.
- What does single reportable — income tax expense benefit mean?
- This metric represents the provision for income taxes associated with the earnings of the specific business segment. It reflects the tax burden or benefit derived from the segment's jurisdictional operations and tax planning strategies. Investors use this to determine the net contribution of the segment to the company's overall after-tax earnings.
Ask your AI about Merit Medical Systems's single reportable — income tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude